Financhill
Back

Regenxbio Vs. Sarepta Therapeutics Industry Stock Comparison

Sell
44

RGNX
Regenxbio

Last Price:
16.01
Seasonality Move:
7.34%
Sell
50

SRPT
Sarepta Therapeutics

Last Price:
132.67
Seasonality Move:
8.89%
Sell
44
Regenxbio (RGNX) is a Sell

Is Regenxbio a Buy, Sell or Hold?

  • The current Regenxbio [RGNX] share price is $16.23. The Score for RGNX is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
  • RGNX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
50
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $132.50. The Score for SRPT is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

RGNX Stock Price Chart

What is Regenxbio's stock price today?

  • The Regenxbio share price today is $16.23
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RGNX is experiencing slight selling pressure.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $132.50
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.

RGNX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.67 Sell
Relative Strength Index (14 RSI): 42.95 Sell
Chaikin Money Flow: -190837 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (15.57 - 17.37) Sell
Bollinger Bands (100): (14.59 - 20.73) Sell

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 2.38 Buy
Relative Strength Index (14 RSI): 60.06 Buy
Chaikin Money Flow: -529387 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (119.82 - 133.16) Buy
Bollinger Bands (100): (111.37 - 133.05) Buy

RGNX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 16.18 Buy
20-day SMA: 16.11 Buy
50-day SMA: 18.97 Sell
200-day SMA: 17.65 Sell
8-day EMA: 16.07 Buy
20-day EMA: 16.56 Sell
50-day EMA: 17.58 Sell
200-day EMA: 18.27 Sell

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 133.09 Sell
20-day SMA: 128.08 Buy
50-day SMA: 125.92 Buy
200-day SMA: 113.27 Buy
8-day EMA: 132.09 Buy
20-day EMA: 129.71 Buy
50-day EMA: 126.49 Buy
200-day EMA: 117.96 Buy

Regenxbio Earnings Growth & RGNX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.23 per share, an increase next quarter of $2.06 per share, an increase this year of $0.57 per share, and an increase next year of $2.96 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.06 per share, an increase next quarter of $1.31 per share, an increase this year of $6.16 per share, and an increase next year of $6.01 per share.

Regenxbio Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):